NES Transdermal Spray
Nestorone (NES) Metered Dose Transdermal System® (MDTS®)
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Transdermal
-
Intended Duration:
- Short-Acting
- Development Stage: Phase I
- Developer(s)/researcher(s): Population Council, Acrux, Ltd., Fempharm Pty Ltd.
Details
- API: Nestorone
- Target: Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: Undetermined
- Regimen: 1 Application/Day
- MPT: Not Potential MPT
Product Status
No public indication of further development after 2007